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Open access under CC BY-NPerﬂuorinated compounds (PFCs), such as perﬂuorooctane sulfonate (PFOS) and perﬂuorooctanoic acid
(PFOA), are used in large quantities. They are persistent and found in measurable levels in human serum
around the world. They have been associated with developmental, hepatic, and carcinogenic effects in
animal studies. The aim of the present study was to describe levels of PFCs in serum among Inuits from
Greenland and inhabitants from Warsaw, Poland and Kharkiv, Ukraine. Furthermore, the aim was to
deﬁne social- and lifestyle related determinants of exposure for these compounds. Serum levels of seven
PFCs were analyzed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). The concentra-
tions of PFOS and PFOA were the highest of all PFCs in all three populations with a total amount of almost
90% of the PFCs. The mean levels of PFOS and PFOA were in the Greenlandic Inuits 52 and 4.8 ng mL1, in
Poland 19 and 5.2 ng mL1, and in Ukraine 8.1 and 1.9 ng mL1, respectively. Thus, levels of PFCs in the
serum of Inuits on Greenland were among the highest described in a general population whereas the
levels in Poland were similar to other industrialized countries. The exposure in Ukraine was rather
low. In the Greenlandic Inuit population, intake of seafood, tea, age and area of living were signiﬁcant
determinants of PFOS concentrations and explained about 22% of the variation. For the other populations
no strong determinants were found.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Perﬂuorinated compounds (PFCs), such as perﬂuorooctane sul-
fonate (PFOS) and perﬂuorooctanoic acid (PFOA), have since the
1950s been used in large quantities in a number of applications
such as in surface coatings, making products water- and oil resis-
tant, and ﬁre ﬁghting foams. In addition, several of the compounds
are approved for use in food containers and cooking pans (e.g. Tef-
lon) and may thus be transferred to food (Fromme et al., 2009).
The annual production of PFCs is in the range of several hundred
metric tons per year (Lau et al., 2004).
The use of PFOS and PFOA has decreased in the last years and as
a result, levels in human matrices are declining (Harada et al.,
2004, 2007; Olsen et al., 2005, 2007, 2008; Calafat et al., 2007;46 46143702.
ndh).
C-ND license.Jin et al., 2007; Haug et al., 2009; Wilhelm et al., 2009; Sundström
et al., 2011; Axmon et al., in preparation). However, PFOS and PFOA
have been substituted by other PFCs, such as perﬂuorononanic acid
(PFNA), perﬂuorodecanic acid (PFDA) and perﬂuoroundecanoic
acid (PFUnDA). Consequently, human levels of the latter com-
pounds have been found to be increasing (Calafat et al., 2007; Haug
et al., 2009; Axmon et al., in preparation).
In animal studies, PFCs have been found to be associated with
several outcomes, such as cancer, neurobehavior and reproductive
health problems (Luebker et al., 2005; Lau et al., 2007; Chang et al.,
2008; Jensen and Leffers, 2008; Johansson et al., 2008; DeWitt
et al., 2009; Sonne, 2010). Furthermore, the evidence of effects
on humans in the general population is increasing. In utero expo-
sure to PFOS and PFOA has been suggested to decrease birth weight
(Apelberg et al., 2007; Fei et al., 2007; Stein et al., 2009; Washino
et al., 2009) as well as weight in early childhood (Andersen et al.,
2010). Moreover, associations have been found between body
Table 1
Background characteristics for 196 Inuit men (Greenland), 190 men from Warsaw
(Poland), and 203 men from Kharkiv (Ukraine).
Greenland Poland Ukraine
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homeostasis and metabolic syndrome (Lin et al., 2009), attention
deﬁcit/hyperactivity disorder (ADHD) (Hoffman et al., 2010) and
thyroid function (Dallaire et al., 2009a).
The PFCs are biopersistent compoundswith half-lives in humans
that have been estimated to be between 3 and 9 years (Olsen et al.,
2007, 2008; Bartell et al., 2010; Brede et al., 2010; Nilsson et al.,
2010; Seals et al., 2011). Thus, they will accumulate in humans. In
recent years there have been many publications describing serum
levels in different populationsworldwide (Kannan et al., 2004; Kuk-
lenyik et al., 2004; Guruge et al., 2005; Falandysz et al., 2006; Kärr-
man et al., 2006, 2007; Calafat et al., 2007; Fromme et al., 2007;
Weihe et al., 2008; Harada et al., 2009, 2010; Rylander et al.,
2009a,b; Hanssen et al., 2010; Hemat et al., 2010; Ingelido et al.,
2010; Roosens et al., 2010; Vassiliadou et al., 2010; Zhang et al.,
2010). Generally, levels in industrialized countries are higher (10–
30 ng PFOS mL1) than in developing countries (few ng PFOS mL1),
although levels in the general population seem to be much lower
than those of occupational exposedworkers (lg PFOS mL1) (From-
me et al., 2009). However, measurements in many populations are
still missing or insufﬁcient. One such population is the Greenlandic
Inuits where only recently levels in breast cancer cases and controls
have been described (Bonefeld-Jorgensen et al., 2011). The levels in
the controls were similar to those found in other industrialized
countries. This is in accordance with results from Canadian Inuits
(Dallaire et al., 2009b; Château-Degat et al., 2010). However, the lev-
els may be expected to be high in certain areas of Greenland with
high intake of local animals, as animals living in polar areas have ele-
vated levels of PFC (Jensen and Leffers, 2008).
There is some information about determinants of PFCs in human
samples. Diet has been found to be a major determinant (Fromme
et al., 2009; Vestergren and Cousins, 2009; Egeghy and Lorber,
2011; Haug et al., 2011). Among foods suggested to account for this
is seafood (Falandysz et al., 2006; Dallaire et al., 2009b; Rylander
et al., 2009a;Haug et al., 2010a),meat (Halldorsson et al., 2008;Haug
et al., 2010a), poultry, frozen entrées, fast food, and microwave pop-
corn (Tittlemier et al., 2007) and peppers, cakes and cookies, lunch-
meats, and green vegetables (Ostertag et al., 2009).While food seems
to be the most important source of exposure in the general popula-
tion, some studies have indicated a substantial contribution also
from dust and air (Fromme et al., 2009; Gewurtz et al., 2009; Harrad
et al., 2010; Egeghy and Lorber, 2011; Haug et al., 2011).
Even though some exposure routes for PFCs are well known,
this only explains a small proportion of the differences in the hu-
man PFC levels. Studies on possible determinants such as age
(Harada et al., 2004; Kannan et al., 2004; Calafat et al., 2006; From-
me et al., 2007; Jin et al., 2007; Olsen et al., 2008; Rylander et al.,
2009a,b Wilhelm et al., 2009; Haug et al., 2010a) and gender
(Fromme et al., 2009) have so far been inconclusive. Thus, further
studies are needed.
In this study, we report serum levels of seven PFCs from Inuit
men on Greenland and male inhabitants from Warsaw, Poland
and Kharkiv, Ukraine. Furthermore, we investigate determinants
of exposure to these PFCs. Such knowledge is important e.g. for risk
evaluations and measures for decreasing exposure. The large vari-
ation in PFC levels between the different populations may consti-
tute a valuable basis for studies of dose–response studies of
different health effects.Age (year) 30 30 25
Median (5th, 95th perc) (20, 43) (25, 37) (19, 39)
BMI (kg m2) 25.5 25.4 24.0
Median (5th, 95th perc) (20.4, 32.1) (20.4, 31.8) (19.6, 29.5)
Tea (cups d1) 2 2 2
Median (5th, 95th perc) (0, 6) (0, 5) (1, 5)
Seafood (d week1) 2 1 4
Median (5th, 95th perc) (0, 6) (0, 3) (2, 5)2. Materials and methods
2.1. Subjects and data collection
The study population has been described in detail previously
(Jönsson et al., 2005). In this study, male subjects delivering semensamples from Greenland, Poland and Ukraine were investigated.
Serum samples were obtained from 196 Greenlandic Inuit males,
190 men from Poland and 203 men from Ukraine in the years
2002–03. Demographic data are shown in Table 1. The study was
approved by the local ethical committees representing all partici-
pating populations and all subjects signed an informed consent.
2.2. Interview data
Information on lifestyle, medical and reproductive history was
collected through interviews. In the present study we used infor-
mation on age, height and weight (for calculation of BMI), smoking
habits, intake of seafood and tea consumption at baseline. For the
population from Greenland we also used information regarding
area of living, due to different life-styles between different areas,
exempliﬁed by different nutrition habits, which might affect PFC
levels.
2.3. Collection of blood samples
Blood samples were drawn from a cubital vein into 10 mL vac-
uum tubes for serum collection without additives (Becton Dickin-
son, Maylan, France). After cooling to room temperature the
tubes were centrifuged at 4000g for 15 min. Serumwas transferred
with ethanol rinsed Pasteur pipettes to ethanol rinsed brown glass
bottles (Termometerfabriken, Gothenburgh, Sweden). A piece of
aluminum foil was placed on top of the bottles which were then
sealed. Sera were stored at 20 C until shipment, but refrigeration
was accepted for up to 4 d. After the arrival at the analyzing labo-
ratory the samples were stored at 80 C until analyzed.
2.4. Analysis of PFCs
The analyses of PFHxS, PFOS, PFOA, PFNA, PFDA, PFUnDA and
perﬂuorododecanoic acid (PFDoDA) were performed by LC/MS/
MS. Aliquots of 100 lL serum were added with 10 lL glucoroni-
dase, 10 lL ammonium acetate buffer, 10 lL methylumbelliferyl-
b-D-glucuronide and 25 lL of a water:acetonitrile (50:50) solution
containing 13C- or 18O-labeled internal standards for all evaluated
compounds and digested at 37 C for 90 min. The proteins were
precipitated with 175 lL acetonitrile and vigorously shaking for
30 min. The samples were thereafter centrifuged at 4200g and
3 lL of the supernatant was injected on a LC (UFLCXR, SHIMADZU
Corporation, Kyoto, Japan; LC/MS/MS) using hybrid triple quadru-
pole linear ion trap mass spectrometry equipped with a TurboIon-
Spray source (QTRAP 5500, Applied Biosystems). The column used
was a C8 column (4 lm, 2.1 mm i.d.  20 mm GENISIS; Grace Vy-
dac, Hesperia, CA, USA). The mobile phase was A: 0.1% ammonia
(NH3) in water and B: 0.1% NH3 in acetonitrile. The mobile phase
was kept at 25% B for 1 min after injection. A gradient was then ap-
plied in 3 min to 95% B where it was kept for 1 min. The column
was then conditioned at 25% B for 3 min. Air was used as nebulizer
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collision gas. The temperature of the ion source was set at 500 C
and the declustering potential was 80 V. The MS analyses were
carried out using selected reaction monitoring (SRM) in the nega-
tive ion mode. SRM transitions and collision energies (CEs) used
in the analysis are described in Table 2.
About 100 samples were analyzed in each batch. The results re-
ported is the average of the two measurements from the same
sample worked-up and analyzed on different days. These results
were also used to calculate the reproducibility of the method (Ta-
ble 2), determined as the coefﬁcient of variation (CV) of the dupli-
cate samples. The limits of detection (LOD), determined as the
concentrations corresponding to three times the standard devia-
tion of the responses in chemical blanks, are also shown in Table
2. In all sample batches, the quality of the measurements was con-
trolled by analyzing chemical blanks and in-house quality control
samples, prepared from a large volume of serum spiked with small
amounts of different PFCs. The analyses of PFOS and PFOA are part
of the Round Robin inter-comparison program (Professor Dr. med.
Hans Drexler, Institute and Out-Patient Clinic for Occupational,
Social and Environmental Medicine, University of Erlangen-
Nuremberg, Germany) with results within the tolerance limits,
determined as three times the standard deviation of the results
from special reference laboratories.
2.5. Statistics
For levels below the LOD the numbers obtained in the evalua-
tion of the MS data were used assuming that these values also have
some meaning. Mann–Whitney tests were used for pairwise com-
parisons of the PFC exposure concentrations between countries
(Greenland vs. Poland, Greenland vs. Ukraine, and Poland vs. Uk-
raine). Separate analyses for each population were performed
regarding correlations between PFOS, PFOA and the other PFCs as
well as evaluation of the impact of different determinants. The cor-
relations between PFOS, PFOA and the other PFCs were evaluated
by Spearman’s correlation coefﬁcients. The impact of potential
determinants on inter-individual variations in PFOS and PFOA ser-
um concentrations were assessed by linear regression models. As
PFOS and PFOA were essentially normally distributed no transfor-
mation was performed. Model assumptions were checked by
analysis of residuals. The determinants evaluated were age (con-
tinuous), BMI (continuous), smoking (categorical: never, ex-smo-
ker and current smoker), seafood (days per week) and tea
consumption (cups d1). In addition, the impact of area of resi-Table 2
Parameters for analysis, limit of detection levels and reproducibilitya for the analyzed com
PFC SRM transition Collision energy (V) Limit of det
PFHxS 399/99 80 0.06
PFOS 499/99 85 0.2
PFOA 413/169 25 0.6
PFNA 463/419 15 0.2
PFDA 513/469 16 0.2
PFUnA 563/519 19 0.3
PFDoA 613/569 25 0.07
18O2-PFHxS 403/103 80 –
13C4-PFOS 503/99 110 –
13C4-PFOA 417/169 30 –
13C5-PFNA 468/423 15 –
13C3-PFDA 515/470 16 –
13C2-PFUnA 565/520 19 –
13C2-PFDoA 615/570 25 –
a Determined as the coefﬁcient of variation (CV) of duplicate samples worked-up and
b The mean concentration for the samples from which the reproducibility was determdence was assessed for the Greenlandic Inuits divided into three
categories: (Mid: (Nuuk, Sisimiut, Maniitsoq and Paamiut),
South/East: (Narsaq, Qaqortoq, Nanortalik, Tasiilaq, Kulusuk and
Kuummiit) and North: (Kangaatsiaq, Aasiaat, Ilulissat, Qeqertar-
suaq, Qasigiannguit, Uummannaq, Qaanaaq, Illorsuit, Saattut and
Ukkusissat)).
The objective of the multivariate model building was to evalu-
ate the impact of each of the determinants. In the ﬁrst step we
evaluated the associations for one determinant at a time with
the PFOS and PFOA concentrations in serum, respectively. In the
second step we included in the multivariate model all determi-
nants with a p-value below 0.05 in the univariate analyses. How-
ever, if a determinant was statistically signiﬁcant in one
population but not in the others we present the univariate esti-
mates also for the other countries. In the results we also give the
explained variances (adjusted r2 obtained from SPSS™ version 18
for the ﬁnal models. To avoid ecological fallacies in these analyses,
the three populations were analyzed separately.
3. Results
Concentrations of the analyzed PFCs are described in Table 3.
With the exception of PFOA, the highest mean concentration for
each PFC was found in the Greenlandic Inuit population, with the
overall highest concentration displayed by PFOS (mean
52 ng mL1). The mean PFOS concentration in serum for the three
regions in Greenland were: Mid: 44.7 ng mL1, South/East:
59.3 ng mL1, and North: 56.3 ng mL1. For PFOA, the Polish popu-
lation had slightly higher concentrations than the Greenlandic Inu-
its. The dominating PFC in all three populations was PFOS with a
fraction of 80%, 69% and 68%, of the total PFCs on weight basis, in
Greenland, Poland and Ukraine, respectively. The second most
dominating PFC was PFOA with a fraction of 7%, 19% and 15%,
respectively, for the three populations. Thus, PFOS and PFOA made
up almost 90% of the PFCs in all three populations.
The numbers of samples below the LOD in the three populations
are included in Table 3. For PFHxS, PFOS, PFOA and PFNA there
were no or just a few samples below the LOD, for PFDA about half
of the Ukraine samples were below the LOD, and for PFUnA and
PFDoA the majority of the samples from Poland and Ukraine were
below the LOD.
Correlations between PFOS and PFOA and the other PFCs in the
three populations are included in Table 4. In the Greenlandic Inuit
population there were high correlations between PFOS and most
PFCs (rS between 0.65 and 0.79) except for PFOA where the corre-pounds.
















analyzed on different days.
ined.
Table 3
Concentrations (ng mL1) of the analyzed PFCs in Inuits from Greenland and
inhabitants from Warsaw, Poland and Kharkiv, Ukraine and the number of samples
below the limit of detection.
Greenland Poland Ukraine
n = 196 n = 190 n = 203
PFHxSa,b,c
Mean (SD) 2.88 (2.54) 1.22 (0.44) 0.40 (0.30)
Median (min, max) 2.18 (0.91, 20.5) 1.18 (0.43, 3.78) 0.34 (<LODd, 3.42)
Samples below LOD 0 0 1
PFOSa,b,c
Mean (SD) 51.9 (24.4) 18.6 (5.67) 8.08 (3.98)
Median (min, max) 44.7 (12.3, 161) 18.5 (8.20, 40.2) 7.60 (2.77, 29.9)
Samples below LOD 0 0 0
PFOAb,c
Mean (SD) 4.83 (1.60) 5.25 (2.14) 1.79 (2.75)
Median (min, max) 4.54 (1.52, 13.7) 4.84 (1.48, 16.0) 1.29 (<LOD, 35.0)
Samples below LOD 0 0 16
PFNAa,b,c
Mean (SD) 2.26 (1.74) 1.32 (0.69) 1.13 (0.54)
Median (min, max) 1.74 (0.53, 11.6) 1.19 (0.48, 6.11) 1.02 (0.25, 4.19)
Numbers below LOD 0 0 0
PFDAa,b,c
Mean (SD) 1.08 (0.81) 0.41 (0.17) 0.23 (0.14)
Median (min, max) 0.87 (<LOD, 5.92) 0.38 (<LOD, 1.37) 0.21 (<LOD, 0.96)
Samples below LOD 2 11 99
PFUnDAa,b
Mean (SD) 1.76 (1.74)
Median (min, max) 1.28 (<LOD, 13.4) <LOD (<LOD, 0.70) <LOD (<LOD, 0.53)
Samples below LOD 11 168 178
PFDoDAa,b,c
Mean (SD) 0.19 (0.20)
Median (min, max) 0.14 (<LOD, 1.68) <LOD (<LOD, 0.23) <LOD (<LOD, 0.10)
Samples below LOD 38 174 197
a Signiﬁcant difference (p < 0.05) between Greenland and Poland (Mann–Whit-
ney test).
b Signiﬁcant difference (p < 0.05) between Greenland and Ukraine (Mann–Whit-
ney test).
c Signiﬁcant difference (p < 0.05) between Poland and Ukraine (Mann–Whitney
test).
d Below the limit of detection.
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and the other PFCs were lower (rS < 0.30). In the Ukrainian popula-
tion there were moderate to high correlations (rS = 0.39–0.72) be-
tween PFCs, while the correlations between PFCs in the Polish
population were low to moderate (rS = 0.10–0.53).
Among the Greenlandic Inuits, age, intake of tea and area of liv-
ing were signiﬁcantly associated with PFOS serum concentrations
(Table 5). Together, they explained 19% of the variation. If we also
included intake of seafood, the explained variance increased to
22%. Moreover, excluding one of the variables intake of seafood
or area of living in the models did not change the estimate of the
remaining variables, speaking in favor of these two variables as
independent. In Poland, the only signiﬁcant determinant was BMITable 4
Spearman’s correlations coefﬁcientsa (and p-values) between PFOS, PFOA and the other PF
Greenland Warsaw (Pol
n = 196 n = 190
PFOS PFOA PFOS
PFHxS 0.65 (<0.001) 0.20 (0.01) 0.44 (<0.001
PFOA 0.42 (<0.001) 0.34 (<0.001
PFNA 0.76 (<0.001) 0.18 (0.01) 0.43 (<0.001
PFDA 0.79 (<0.001) 0.16 (0.02) 0.37 (<0.001
PFUnDA 0.69 (<0.001) 0.05 (0.51) –
PFDoDA 0.65 (<0.001) 0.04 (0.50) –
a Correlation coefﬁcients were only calculated when we had data above LOD for at leand in Ukraine there was no statistically signiﬁcant determinant.
Regarding PFOA, the only signiﬁcant association was observed for
tea consumption among the Greenlandic Inuits. An increase of
one cup per day corresponded to an increase in PFOA of
0.17 ng mL1 (95% CI, 0.05, 0.29; R2 = 0.04). Smoking was not asso-
ciated with PFOS or PFOA.
4. Discussion
The present study provides data on levels of PFCs in populations
for which such information is lacking or only scarce. The levels
among Inuits in Greenland were among the highest described in
the literature. Levels in Poland were similar to other industrialized
populations while those in Ukraine were lower. Determinants
found in most cases seemed to be similar to previous studies
(Fromme et al., 2009; Haug et al., 2010a). However, the ﬁnding
of different levels of PFOS in different areas of Greenland was no-
vel. Also, the ﬁnding of tea consumption as a determinant for both
PFOS and PFOA was not previously reported.
For the purpose of this study we developed a simple method for
determination of several PFCs. The method uses only 0.1 mL serum
and may therefore be suitable to apply on samples stored in serum
banks. The coefﬁcient of variation of duplicate samples worked-up
and analyzed on different was generally below 10% for duplicate
analysis of the same sample, analyzed in different sample batches
on different days. Moreover, the detection limits were sufﬁcient for
determination of levels in most samples. Furthermore, a high accu-
racy of the method, at least for PFOS and PFOA, was proven by par-
ticipation in an inter-laboratory control program. However, it
should be emphasized that a quantitative comparison of the pre-
sented data, especially with earlier published data, must be done
with caution since there have been many challenges in the devel-
opment of analytical methods for the PFCs over time (Martin et al.,
2004).
The levels of PFOS in the Inuits on Greenland indicate that these
are among the highest exposed populations in the world and was
higher than those at 22 ng mL1 reported by Bonefeld-Jorgensen
et al. (2011) for the controls in their study. This is in accordance
with the high levels found in animals living in the Arctic area.
Moreover, the results show that the Greenlandic Inuit population
is highly exposed to several other, more recently industrially intro-
duced PFCs, such as PFNA, PFDA, PFUnA and PFDoA. This indicates a
fast distribution of these compounds to the Arctic area. Interest-
ingly, the levels of PFOA on Greenland were similar to the levels
found in industrialized countries in Europe and the US.
Previous studies on Polish populations have found that people
with a high consumption of ﬁsh from or residing by the Baltic
Sea have considerably higher levels of PFCs than non-ﬁsh eating
populations (Kannan et al., 2004; Falandysz et al., 2006). In the
present study, the levels of PFCs in Poland were comparable to
those found in Polish non-ﬁsh eating populations. This was to be




) 0.23 (<0.001) 0.72 (<0.001) 0.49 (<0.001)
) 0.56 (<0.001)
) 0.53 (<0.001) 0.57 (<0.001) 0.39 (<0.001)
) 0.44 (<0.001) – –
– – –
– – –
ast 60% of the participants.
Table 5
Linear regressions (univariate and multivariate models) for determinants for PFOS serum concentrations (ng/mL) among Inuit men (Greenland), Warsaw men (Poland), and
Kharkiv men (Ukraine). Signiﬁcant associations are marked with bold text. In addition, explained variances (R2) are shown.
Greenland Poland Ukraine
Univariate Multivariate Univariate Univariate
Determinants b 95% CI b 95% CI b 95% CI b 95% CI
Age (yr) 0.87 (0.38, 1.4) 0.84 (0.36, 1.3) 0.062 (0.14, 0.27) 0.008 (0.10, 0.087)
BMI (kg/m2) 0.37 (1.2, 0.42) – 0.26 (0.50, 0.014) 0.003 (0.18, 0.17)
Tea (cups/day) 2.6 (0.88, 4.2) 2.1 (0.52, 3.6) 0.38 (0.21, 0.97) 0.33 (0.77, 0.10)
Seafood (days/week) 3.0 (1.1, 4.9) 2.1 (0.24, 3.9) 0.74 (0.095, 1.6) 0.042 (0.40, 0.48)
Area (North reference)
South/East 3.0 (6.0, 12) 0.67 (8.0, 9.4) – –
Mid 12 (20, 3.4) 13 (21, 5.8) – –
Adjusted R2 0.22 0.02a –b
a Including only BMI in the model.
b No signiﬁcant associations.
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tic Sea ﬁsh. Some earlier pilot studies in Warsaw showed even
somewhat lower levels of PFCs conﬁrming lower exposure of
inlanders (Strucinski et al., 2006). The levels of PFCs in Poland were
in the same range as for other industrialized countries (Fromme
et al., 2009).
To the best of our knowledge, there are no previous reports of
levels of PFCs in Ukraine. The levels found in this study indicate
a rather low exposure compared to most industrialized countries.
For PFOS the levels were similar to those at about 10 ng mL1
found in Brazil and Colombia (Kannan et al., 2004).
Although PFOS correlated well with all other PFCs, except with
PFOA, the correlations between PFOA and the other PFCs were low.
One interpretation is that the exposure routes for PFOS differ from
those for PFOA. E.g. difference in PFOS and PFOA ﬁsh concentra-
tions has been observed that could indicate a lower potential of
PFOA to bioaccumulate in ﬁsh than PFOS (Fromme et al., 2009).
Thus, it is not surprising that we found different determinants
for PFOA and PFOS.
We found signiﬁcant determinants for PFOS only in the Green-
landic Inuit population. Possible explanations for this may include
higher levels of PFOS among the Greenlandic Inuits than in Poland
or Ukraine, but also a difference in exposure levels from the same
exposure routes, e.g. that seafood consumed on Greenland carries a
higher exposure than the same amount consumed in Poland. Still,
only 22% of the Greenlandic Inuit’s PFOS levels were explained by
the determinants investigated.
In the Greenlandic Inuit population, seafood was one of the
determinants for PFOS. PFOS and – although to a lesser extent –
PFOA have been found in both freshwater and marine ﬁsh species
world wide (D’Hollander et al., 2010). Accordingly, studies relating
ﬁsh and shellﬁsh consumption to human levels of PFCs have gen-
erally found positive correlations (Falandysz et al., 2006; Rylander
et al., 2009a,b; Haug et al., 2010a), although not always for PFOA
(Rylander et al., 2009a,b). Thus, the results in the present study
are in agreement with previous research.
Unfortunately we have no information regarding the Greenlan-
dic Inuit’s seafood consumption was related to consumption of ﬁsh
or marine mammals. In some studies, consumption of marine
mammals has been associated with high levels of PFCs in serum;
Weihe et al. (2008) found a relationship between PFCs in serum
of consumers of Faroese whale meat. In the present study, we
found higher levels of PFOS but not PFOA in the remote areas of
Greenland, where the diet tend to consist of more traditional
Greenlandic Inuit food with consumption of ﬁsh and marine mam-
mals, than in Nuuk, the capital of Greenland. Thus, the traditional
Greenlandic Inuit food is most likely related to a higher exposure.
In agreement with our study, Dallaire et al. (2009a,b) did not ﬁndthat the remote geographical location and traditional lifestyle pro-
tected the Canadian Nunavi Inuits from PFOS exposure.
Previous studies on a possible relationship between age and
PFCs are inconclusive. Whereas some have found increasing levels
of PFOS with increasing age (Olsen et al., 2005; Kärrman et al.,
2006; Fromme et al., 2007; Rylander et al., 2009a,b; Haug et al.,
2010a), others have failed to show any age related changes for
PFOS or PFOA (Harada et al., 2004; Kannan et al., 2004; Calafat
et al., 2006; Jin et al., 2007; Olsen et al., 2008; Wilhelm et al.,
2009). Similarly, in the present study, different results for age were
found for the different PFCs and the different populations. The
inﬂuence of age on the levels of PFCs should be further investi-
gated, especially considering that since environmental levels of
PFCs have not been at a steady state during the past decades, age
is not necessarily a proxy for exposure time.
In Poland there was an inverse relationship between PFOS and
BMI. The effect estimate was similar in the Greenlandic population,
although not statistically signiﬁcant. A similar relationship has
been found in the Danish general population (Eriksen et al.,
2011) and a German population exposed to PFCs through contam-
inated drinking water (Hölzer et al., 2008). However, other studies
have not shown such an association (Halldorsson et al., 2008;
Rylander et al., 2009a,b). There was no expectation of ﬁnding an
association with BMI since PFCs are mainly bound to proteins
and not fat. We can therefore not rule out that in the Polish popu-
lation, BMI is a proxy for an unmeasured determinant, such as diet.
It is interesting to note that tea seemed to be a determinant for
PFOS and PFOA in the Greenlandic Inuit population. However, tea
consumption was not a determinant of PFOS and PFOA level in Po-
land or Ukraine, with similar tea consumption as the Greenlandic
Inuits. High levels of PFCs in tea could be a result of either high lev-
els in the water with which the tea was brewed, from the tea
leaves themselves or from the container (e.g. tea bag or tea infuser
for home brewed tea or bottle for ready made tea, such as iced tea).
Drinking water is generally not thought of as a major exposure
source for PFCs. In most studies, its contribution to the daily intake
of PFOS and PFOA has been found to be below 3% (Thompson et al.,
2011). However, in some reports, it has been estimated to be as
high as 55% (Noorlander et al., 2011; Thompson et al., 2011). We
have found no reports on PFC levels in Greenlandic drinking water,
and it is therefore difﬁcult to draw any conclusions about the pos-
sibility that the water is the contributing factor the results found
for tea consumption. In a study from Sri Lanka, workers from a rur-
al conventional tea cultivation area had levels of PFOS and PFOA
that were in the same range as people from the county’s capital
(Guruge et al., 2005). However, workers involved in organic tea
cultivation had considerably lower levels of both PFOS and PFOA.
Thus, there is the possibility that something in the conventional
1274 C.H. Lindh et al. / Chemosphere 88 (2012) 1269–1275tea cultivation might cause PFC contamination. Indeed, Haug et al.
(2010a,b) measured PFCs in a small sample of brewed tea, and
found that the levels of PFOA but not PFOS were considerably high-
er in the prepared drink than in the water it was made from. Thus,
it is possible that both water and tea leaves can contribute to the
results found in this study.5. Conclusion
The levels of PFCs in serum of Inuits on Greenland were among
the highest described in a general population, whereas the levels in
a population from Warsaw, Poland were similar to other industri-
alized countries. The levels in Ukraine were rather low. Determi-
nants for PFOS on Greenland were seafood and tea intake, age
and area of living. Tea was also a determinant of PFOA at Green-
land. For the other populations no strong determinants were
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